Isordil
$ 51,00 – $ 151,00Price range: $ 51,00 through $ 151,00
Iverheal
$ 50,00 – $ 880,00Price range: $ 50,00 through $ 880,00
Isotroin
$ 41,00 – $ 513,00Price range: $ 41,00 through $ 513,00
Isotroin is a potent oral retinoid specifically designed to combat severe, recalcitrant nodular acne. It works by targeting the sebaceous glands to significantly decrease oil production and reduce inflammation within the pores. This medication is primarily indicated for patients whose acne has not responded to other standard treatments, including systemic antibiotics. By effectively clearing deep-seated nodules, it helps to minimize the risk of permanent skin scarring and improves overall complexion. Consistent use of Isotroin promotes a long-term reduction in breakouts and restores a healthier appearance to the skin.
Active substance: Isotretinoin
SKU:
Isotroin
Category: Skin Care
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Isotroin – Patient Information Guide
Isotroin belongs to a group of systemic retinoids, which are synthetic compounds structurally related to vitamin A. It is prescribed in the United States for severe, recalcitrant nodular acne that has failed to clear following standard treatment protocols, including oral systemic antibiotics.
As a prescription-only pharmaceutical, Isotroin is subject to strict regulatory oversight by the U.S. Food and Drug Administration (FDA) and must be dispensed in compliance with federal safety mandates to prevent fetal exposure and ensure appropriate clinical monitoring.
| Drug name | Isotroin |
| Active ingredient (INN) | Isotretinoin |
| Therapeutic class | Systemic Retinoids |
| Dosage form | Oral soft gelatin capsule |
| Route of administration | Oral |
| Prescription status | Prescription (Rx only) |
How the drug works
The mechanism of action of Isotroin involves the inhibition of sebaceous gland function and the reduction of sebaceous gland size. By decreasing sebum secretion, the medication alters the microenvironment of the skin follicle, thereby diminishing follicular colonization by Cutibacterium acnes (formerly known as Propionibacterium acnes). Additionally, the compound normalizes keratinization within the pilosebaceous unit, inhibiting hypercornification that leads to microcomedone formation. This combined action reduces both inflammatory and non-inflammatory acne lesions over a course of systemic therapy.
What it’s used for
The primary FDA-approved indication for Isotroin is the treatment of severe recalcitrant nodular acne in patients 12 years of age and older. A nodule is defined as an inflammatory lesion with a diameter of 5 mm or greater. Due to significant potential adverse effects, its use is reserved for cases where conventional therapies, including systemic antibacterial agents, have proven ineffective. Certain clinical conditions, such as severe recalcitrant rosacea, gram-negative folliculitis, or hidradenitis suppurativa, may occasionally be managed with systemic isotretinoin as an off-label use under the direct judgment of a licensed healthcare provider.
Dosing Schedule and Administration
The recommended dosage of Isotroin must be calculated individually based on the patient’s body weight and clinical response. The typical daily dose ranges from 0.5 mg/kg to 1.0 mg/kg, administered in two divided doses daily over a period of 15 to 20 weeks. In cases of severe disease or trunk involvement, doses may be adjusted up to a maximum of 2.0 mg/kg daily. To ensure optimal systemic absorption, each dose should be ingested with food, as high-fat meals significantly enhance bioavailability. Adjustments to the dosing schedule may be required for patients presenting with renal impairment or severe intolerance during the course of treatment.
What happens in the body
Following oral administration, absorption of Isotroin is variable, but peak plasma concentrations are reached within 2 to 4 hours when taken with a meal. The drug is highly bound to plasma proteins, predominantly serum albumin (exceeding 99%). Metabolism occurs primarily in the liver via cytochrome P450 enzymes, yielding several metabolites, including 4-oxo-isotretinoin, which possesses biological activity comparable to the parent compound. The terminal elimination half-life of isotretinoin ranges from approximately 10 to 20 hours, whereas the half-life of the 4-oxo metabolite ranges between 17 and 50 hours. Elimination occurs in roughly equal proportions through renal and biliary routes.
Compatibility with other medicines
Isotroin exhibits several clinically significant drug interactions. Concomitant administration with vitamin A supplements must be avoided due to the heightened risk of additive hypervitaminosis A toxicity. Concurrent use with tetracycline-class antibiotics (such as doxycycline, tetracycline, or minocycline) is strictly contraindicated because the combination increases the risk of developing pseudotumor cerebri (benign intracranial hypertension). Microdose progesterone-only contraceptives (“mini-pills”) may experience reduced efficacy when taken alongside systemic retinoids; therefore, primary barrier or non-hormonal methods should be evaluated. Systemic corticosteroids should be monitored carefully due to cumulative effects on bone density loss.
What side effects may occur
The adverse effect profile of Isotroin is largely related to mucocutaneous dryness. Very common manifestations include cheilitis, xerosis, dry nasal mucosa leading to epistaxis, dry eyes, and blepharitis. Laboratory abnormalities are frequently observed, including transient elevations in serum triglycerides, serum cholesterol, liver transaminases, and blood glucose levels. Musculoskeletal complaints, such as arthralgia, myalgia, and back pain, are commonly reported, particularly in physically active individuals. Less frequent but severe adverse events include inflammatory bowel disease, decreased night vision, corneal opacities, severe cutaneous reactions, elevated intracranial pressure, and neuropsychiatric events, such as clinical depression and suicidal tendencies.
Important Precautions and Special Populations
Isotroin carries a boxed warning regarding severe teratogenicity. Exposure during pregnancy causes major congenital malformations, including central nervous system anomalies, facial dysmorphism, cardiovascular defects, and thymic gland abnormalities, as well as an increased risk of spontaneous abortion and premature delivery. In the United States, Isotroin is restricted under the FDA-approved iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program. Prescribers, pharmacies, and patients must register and comply with strict program requirements, including baseline and monthly pregnancy testing and the verified use of two simultaneous forms of effective contraception for patients of childbearing potential.
Careful monitoring is required for pediatric patients over 12 years of age regarding potential effects on bone growth, including premature epiphyseal closure. Safety and effectiveness in pediatric patients under 12 years of age have not been established. Patients presenting with preexisting hypertriglyceridemia, diabetes mellitus, or hepatic dysfunction require close baseline and periodic laboratory evaluation throughout the therapeutic course.
Food and alcohol interactions
Administration of Isotroin with food substantially increases peak concentration and overall bioavailability compared to administration under fasting conditions. Patients are advised to take the capsule with a meal containing dietary fats. Alcohol consumption should be restricted or completely avoided during treatment. Concomitant alcohol intake exacerbates the risk of serum triglyceride elevations and increases the potential for cumulative hepatic toxicity, given that both substances undergo hepatic metabolism.
First days of treatment
During the initial 2 to 4 weeks of therapy with Isotroin, patients often observe a temporary flare or worsening of acne lesions. This initial exacerbation is a recognized response associated with accelerated follicular turnover and inflammatory clearing. Early onset of mucocutaneous symptoms, particularly dry lips and dry skin, typically occurs within the first week of initiating treatment. Patients should be counseled that clinical improvement is cumulative and generally becomes evident after several weeks of continuous therapy.
Storage and expiration
Isotroin capsules should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C and 30°C). The medication must be kept in its original blister container to protect the active ingredient from light and moisture. Storage in high-humidity environments, such as bathrooms, should be avoided. The drug must be kept out of reach of children and should not be used beyond the expiration date stamped on the package packaging.
Practical tips
To manage predictable mucocutaneous side effects, patients should begin applying bland emollients and lip balms at the start of treatment. Artificial tears can assist in alleviating dry eye symptoms, especially for contact lens wearers. Due to increased photosensitivity, patients should apply broad-spectrum sunscreen (SPF 30 or higher) daily and avoid prolonged exposure to direct sunlight or artificial ultraviolet sources, such as tanning beds. Aggressive cosmetic procedures–including waxing, chemical peels, and laser skin treatments–must be avoided during therapy and for at least 6 months following completion to prevent scarring or epidermal stripping.
Frequently Asked Questions
Why is participation in the iPLEDGE program mandatory in the United States?
The iPLEDGE REMS program is a mandatory regulatory framework established by the FDA to eliminate fetal exposure to isotretinoin. Because the drug causes severe birth defects, all prescribers, patients, and dispensing pharmacies must be registered in the system to verify negative pregnancy tests and documented contraceptive compliance before each monthly prescription is filled.
Is an initial worsening of acne normal when starting Isotroin?
Yes, a transient flare-up of inflammatory acne lesions is a documented occurrence during the first 2 to 4 weeks of treatment. This reaction occurs as the medication alters sebaceous gland activity and accelerates cell turnover within the hair follicles.
What laboratory tests are routinely monitored during therapy?
Standard monitoring protocols require baseline blood tests prior to starting therapy, followed by periodic evaluations. These tests typically include serum lipid panels (triglycerides and cholesterol), liver function tests (ALT and AST), baseline blood counts, and monthly pregnancy tests for individuals of childbearing potential.
Can contact lenses be worn while taking this drug?
Many patients experience dry eyes due to decreased lipid secretion by the meibomian glands. Intolerance to contact lenses can occur during treatment, and some individuals may need to use lubricating eye drops or temporarily switch to eyeglasses until therapy is completed.
What should be done if a scheduled dose is missed?
If a dose is missed, it should be skipped entirely, and the regular dosing schedule should be resumed at the next scheduled time. Patients must not double the dose to make up for a missed capsule.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
10 mg ,20 mg ,30mg |
|---|---|
| Package |
30 caps ,60 pills ,60 caps ,90 pills ,120 pills ,120 caps ,180 pills ,240 caps ,270 pills ,360 pills ,360 caps |
| Ενεργός Ουσία |
Related products
A-Ret Gel
$ 50,00 – $ 141,00Price range: $ 50,00 through $ 141,00
Active substance: Tretinoin
More Details
This product has multiple variants. The options may be chosen on the product page
Acticin
$ 50,00 – $ 103,00Price range: $ 50,00 through $ 103,00
Active substance: Permethrin
More Details
This product has multiple variants. The options may be chosen on the product page
Aldara Cream
$ 224,00 – $ 1 440,00Price range: $ 224,00 through $ 1 440,00
More Details
This product has multiple variants. The options may be chosen on the product page
Aziderm Cream
$ 11,00 – $ 57,00Price range: $ 11,00 through $ 57,00
Active substance: Azelaic Acid
More Details
This product has multiple variants. The options may be chosen on the product page
Benzac AC Gel
$ 34,00 – $ 104,00Price range: $ 34,00 through $ 104,00
Active substance: benzoyl peroxide
More Details
This product has multiple variants. The options may be chosen on the product page
Dapsone
$ 80,00 – $ 180,00Price range: $ 80,00 through $ 180,00
Active substance: dapsone
More Details
This product has multiple variants. The options may be chosen on the product page
Decadron
$ 12,00 – $ 182,00Price range: $ 12,00 through $ 182,00
Active substance: Dexamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Elimite
$ 44,00 – $ 92,00Price range: $ 44,00 through $ 92,00
Active substance: Permethrin
More Details
This product has multiple variants. The options may be chosen on the product page
